Cargando…
Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer
BACKGROUND: The human epidermal growth factor receptor (HER) family of transmembrane tyrosine kinases is overexpressed and correlates with poor prognosis and decreased survival in many cancers. The receptor family has been therapeutically targeted, yet tyrosine kinase inhibitors (TKIs) do not inhibi...
Autores principales: | Maisel, Sabrina A., Broka, Derrick, Atwell, Benjamin, Bunch, Thomas, Kupp, Robert, Singh, Shiv K., Mehta, Shwetal, Schroeder, Joyce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582486/ https://www.ncbi.nlm.nih.gov/pubmed/31215437 http://dx.doi.org/10.1186/s12967-019-1939-7 |
Ejemplares similares
-
Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration
por: Maisel, Sabrina, et al.
Publicado: (2017) -
EGFR Expression in HER2-Driven Breast Cancer Cells
por: Weinberg, Florian, et al.
Publicado: (2020) -
Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration
por: Greenwood, Erin, et al.
Publicado: (2016) -
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008) -
Influence of Macrocyclization on Allosteric, Juxtamembrane-Derived,
Stapled Peptide Inhibitors of the Epidermal Growth Factor Receptor
(EGFR)
por: Sinclair, Julie K.-L., et al.
Publicado: (2014)